Processing

Please wait...

Settings

Settings

Goto Application

1. WO2005098443 - METHODS FOR THE DIAGNOSIS OF CANCERS OR OF PRECANCEROUS LESIONS

Publication Number WO/2005/098443
Publication Date 20.10.2005
International Application No. PCT/EP2005/003656
International Filing Date 07.04.2005
IPC
G01N 33/574 2006.01
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/-G01N31/131
48Biological material, e.g. blood, urine; Haemocytometers
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
CPC
G01N 33/574
GPHYSICS
01MEASURING; TESTING
NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
33Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
48Biological material, e.g. blood, urine
50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
53Immunoassay; Biospecific binding assay; Materials therefor
574for cancer
Applicants
  • INSERM (Institut National de la Santé et de la Recherche Médicale) [FR]/[FR] (AllExceptUS)
  • CARRIER, Alice [FR]/[FR] (UsOnly)
  • PEBUSQUE, Marie-Josèphe [FR]/[FR] (UsOnly)
Inventors
  • CARRIER, Alice
  • PEBUSQUE, Marie-Josèphe
Agents
  • GROSSET-FOURNIER, Chantal
Priority Data
04290936.608.04.2004EP
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) METHODS FOR THE DIAGNOSIS OF CANCERS OR OF PRECANCEROUS LESIONS
(FR) PROCEDES DE DIAGNOSTIC DE CANCERS OU DE LESIONS PRECANCEREUSES
Abstract
(EN)
The present invention relates to the use of a compound enabling the detection of the substantial lack of expression of the TP53INP1 protein in a biological sample, for the manufacture of a drug intended for the prognosis or the diagnosis of cancers and/or of precancerous lesions, or for the screening of drugs active on cancers.
(FR)
L'invention concerne l'utilisation d'un composé permettant la détection d'un manque sensible d'expression de la protéine TP53INP1 dans un échantillon biologique, destiné à la fabrication d'un médicament utilisé dans le pronostic et le diagnostic de cancers et/ou de lésions précancéreuses, ou dans le criblage de médicaments actifs sur des cancers.
Latest bibliographic data on file with the International Bureau